These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10662706)

  • 1. Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients.
    Jackson NC; Carroll PV; Russell-Jones DL; Sönksen PH; Treacher DF; Umpleby AM
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E226-33. PubMed ID: 10662706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.
    Carroll PV; Jackson NC; Russell-Jones DL; Treacher DF; Sönksen PH; Umpleby AM
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E151-7. PubMed ID: 12759221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.
    Umpleby AM; Carroll PV; Russell-Jones DL; Treacher DF; Jackson NC
    Nutrition; 2002 Feb; 18(2):127-9. PubMed ID: 11844642
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
    Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
    J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: effects on glucose control, plasma IGF-I and glutamine.
    Duska F; Fric M; Pazout J; Waldauf P; Tůma P; Pachl J
    Growth Horm IGF Res; 2008 Feb; 18(1):82-7. PubMed ID: 17709266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition.
    Ney DM
    JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S184-9. PubMed ID: 10571453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats.
    Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Takenaka A; Takahashi S; Noguchi T
    JPEN J Parenter Enteral Nutr; 1996; 20(5):325-31. PubMed ID: 8887900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM
    JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of glutamine metabolism to glutamine-supplemented parenteral nutrition.
    van Acker BA; Hulsewé KW; Wagenmakers AJ; von Meyenfeldt MF; Soeters PB
    Am J Clin Nutr; 2000 Sep; 72(3):790-5. PubMed ID: 10966901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone together with glutamine-containing total parenteral nutrition maintains muscle glutamine levels and results in a less negative nitrogen balance after surgical trauma.
    Hammarqvist F; Sandgren A; Andersson K; Essén P; McNurlan MA; Garlick PJ; Wernerman J
    Surgery; 2001 May; 129(5):576-86. PubMed ID: 11331450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
    Berneis K; Ninnis R; Girard J; Frey BM; Keller U
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parenteral L-glutamine on muscle in the very severely ill.
    Palmer TE; Griffiths RD; Jones C
    Nutrition; 1996 May; 12(5):316-20. PubMed ID: 8875514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs.
    Koea JB; Douglas RG; Breier BH; Shaw JH; Gluckman PD
    Endocrinology; 1992 Aug; 131(2):643-8. PubMed ID: 1639012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic response of muscle to alanine, glutamine, and valine supplementation during severe illness.
    Gore DC; Wolfe RR
    JPEN J Parenter Enteral Nutr; 2003; 27(5):307-14. PubMed ID: 12971729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
    Hatton J; Kryscio R; Ryan M; Ott L; Young B
    J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.